Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Dr Agarwals Eye Hospital Ltd (DRAGARWQ)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526783 NSE: DRAGARWQ Hospital & Healthcare Services | Small Cap | Dr Agarwals Eye Hosp Share Price

₹5,369.45 -4.40 (-0.08%)

As on 24-Aug'26 16:59

Dr Agarwals Eye Hospital Ltd (DRAGARWQ)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526783 NSE: DRAGARWQ Hospital & Healthcare Services | Small Cap | Dr Agarwals Eye Hosp Share Price

₹5,369.45 -4.40 (-0.08%)

As on 24-Aug'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹2,595 Cr.
Current Price
₹5,369.5
52-Week Low / High
₹4,231 / 6,392
TTM EPS
₹157.7
TTM Sales
₹497 Cr.
Book Value per Share
₹764.9
P/E Ratio
34.05
Higher than its 5-year historical median
Industry PE
99.3
Price to Book (P/B)
7.02
In line with its 5-year historical median
Price to Sales (P/S)
5.22
Higher than its 5-year historical median
EV/EBITDA
16.85
Higher than its 5-year historical median
Dividend Yield
0.13%
Profitability Efficiency
Return on Equity (ROE)
25.22%
Outperforms industry median
Return on Capital Employed (ROCE)
29.21%
Outperforms industry median
Return on Assets (ROA)
9.23%
Operating Profit Margin
31.1%
Net Profit Margin
14.89%
Gross Profit Margin
29.6%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
18.56%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
22.81%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
28.27%
Asset Quality
Promoter Holding
72.67%
Pledged shares (%) of Promoter's holding (%)
7.67%
Reserves
₹365 Cr.
Equity
₹4.8 Cr.
Face Value
₹10
All Time Low / High
₹2.10 / 7300.00

Dr Agarwals Eye Hospital stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Very Good
Check detailed performance

Valuation

Somewhat Overvalued

Check Valuation charts

Price Trend

Semi Strong
Check Price chart
Q.1 Is Dr Agarwals Eye Hospital Ltd a good quality company?
Dr Agarwals Eye Hospital Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Dr Agarwals Eye Hospital Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Dr Agarwals Eye Hospital Ltd vs industry peers?
Dr Agarwals Eye Hospital Ltd revenue CAGR is 27.49%, compared to the industry median CAGR of 2.87%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Dr Agarwals Eye Hospital Ltd?
Promoters hold 72.67% of the Dr Agarwals Eye Hospital Ltd, with 7.67% of their stake pledged, indicating low pledge risk.
Q.1 Stock return of Dr Agarwals Eye Hospital Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 39.1% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dr Agarwals Eye Hospital Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ28.3%31.7%34.3%39.9%16.9%42.4%43%38.6%33.3%29.2%-
Value Creation
Index ⓘ		1.01.31.51.90.22.02.11.81.41.1-

Growth Parameters ⓘ
Sales ⓘ149153170176140201268319397471497
Sales YoY Gr.-3.2%10.9%3.5%-20.5%43.9%33.2%19.1%24.4%18.6%-
Adj EPS ⓘ16.214.525.329.3-35178.799115.3143.9157.7
YoY Gr.--10.5%74.2%15.7%-110.3%NA54.4%25.8%16.5%24.7%-
BVPS (₹) ⓘ62.674.697119.4116.3166.3241.2334.4446717764.9
Adj Net
Profit ⓘ		7.66.811.913.8-1.4243746.554.269.576
Cash Flow from Ops. ⓘ20.118.625.138.633.956.769.689.893.6145-
Debt/CF from Ops. ⓘ1.2110.50.60.60.60.610.6-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ13.7%27.5%20.7%18.6%
Adj EPS ⓘ27.4%NA22.3%24.7%
BVPSⓘ31.1%43.9%43.8%60.8%
Share Price 38.8% 68.6% 38% 0.9%

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ		28.921.229.527.1-2.636.138.634.429.62521.3
Op. Profit
Mgn % ⓘ		15.215.917.626.921.429.228.328.930.131.130.5
Net Profit
Mgn % ⓘ		5.14.577.8-111.913.814.613.714.815.3
Debt to
Equity ⓘ		0.80.50.50.30.40.40.40.30.50.2-
Working Cap
Days ⓘ		112117124131150103929410410850
Cash Conv.
Cycle ⓘ		-19-23-22-10-15-30-32-26-15-711

Valuation of Dr Agarwals Eye Hosp - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.0055.4555.4555.4555.4529.2629.2629.267.67
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Sales149153170176140201268319397471
Operating Expenses ⓘ + 126129140129110143192227278325
Manufacturing Costs26273031273547586574
Material Costs353438403347617190101
Employee Cost 32323436323953647892
Other Costs ⓘ 33363922182331354557
Operating Profit ⓘ 2224304730597692119146
Operating Profit Margin (%) 15.0%15.8%17.6%26.8%21.3%29.1%28.3%28.8%30.0%31.1%
Other Income ⓘ + 2223212566
Exceptional Items ⓘ 0000000000
Interest ⓘ 434977881514
Depreciation ⓘ 9101121192020273946
Profit Before Tax ⓘ 1113172063249627194
Tax ⓘ 47667812161624
Profit After Tax 771214-12437465570
PAT Margin (%) 4.9%4.4%7.0%7.8%-1.0%12.0%13.8%14.5%13.8%14.9%
Adjusted EPS (₹)15.614.425.429.1-3.151.378.698.6116.3145.1
Dividend Payout Ratio (%)9.60%8.30%5.90%0%0%5.90%3.80%5.10%5.20%4.80%
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 293546565578113157210346
Share Capital ⓘ 5555555555
Reserves ⓘ 253041515073109152205341
Debt +16101813172740448267
Long Term Debt135138102136448267
Short Term Debt3555764000
Minority Interest0000000000
Trade Payables14181514182627322527
Others Liabilities ⓘ 2233418378203242308361401
Total Liabilities ⓘ 8196120166167333422541677841

Fixed Assets

Net Fixed Assets ⓘ +3336559496214260316393403
Gross Block374978138158295365446493546
Accumulated Depreciation41323446281104131100144
CWIP ⓘ 13000266297128197
Investments ⓘ 000000001389
Inventories6768566101314
Trade Receivables77979910131419
Cash Equivalents 325722292834107
Others Assets ⓘ 3140455136495572105113
Total Assets ⓘ 8196120166167333422541677841
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + 201925393457709094145
PBT ⓘ 1113172063249627194
Adjustment ⓘ 11131328272727315054
Changes in Working Capital ⓘ 1-23-346510-76
Tax Paid ⓘ -3-5-8-7-3-9-12-14-20-9
Cash Flow From Investing Activity ⓘ + -8-11-25-17-11-46-71-70-133-174
Capex -8-11-25-17-11-46-70-70-102-98
Net Investments -00-00-0-0-0-1-30-76
Others ⓘ 110000-0100
Cash Flow From Financing Activity ⓘ + -12-82-20-8-40-141725
Net Proceeds from Shares ⓘ 00000000070
Net Proceeds from Borrowing ⓘ -5-76-621120937-15
Interest Paid ⓘ -3-3-3-3-2-2-2-0-3-1
Dividend Paid ⓘ -0-1-1-1-0-0-1-3-2-3
Others ⓘ -320-10-7-13-17-20-15-26
Net Cash Flow ⓘ 0-022157-16-23-4
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)27.7821.0229.5526.91-2.636.2938.5634.2829.825.22
ROCE (%)28.2631.734.339.8716.9242.442.9838.5933.2629.21
Asset Turnover Ratio1.81.731.571.230.840.80.710.660.650.62
PAT to CFO Conversion(x)2.862.712.082.79N/A2.381.891.961.712.07
Working Capital Days
Receivable Days19.3016.3016.901620.3015.8012.8013.2012.4012.70
Inventory Days19.701614.801517.209.908910.6010.70
Payable Days167170.60159.40131.50175.90170.20156.80151.40115.4093

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Dr Agarwals Eye Hospital Ltd FAQs

The current trading price of Dr Agarwals Eye Hosp on 24-Aug-2026 16:59 is ₹5,369.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Aug-2026 the market cap of Dr Agarwals Eye Hosp stood at ₹2,595 Cr

The latest P/E ratio of Dr Agarwals Eye Hosp as of 23-Aug-2026 is 34.05.

The latest P/B ratio of Dr Agarwals Eye Hosp as of 23-Aug-2026 is 7.02.

The 52-week high of Dr Agarwals Eye Hosp is ₹6,392 and the 52-week low is ₹4,231.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dr Agarwals Eye Hosp is ₹497 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Dr Agarwals Eye Hospital Ltd is a good quality company.

The key valuation ratios of Dr Agarwals Eye Hospital Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Dr Agarwals Eye Hospital Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Dr Agarwals Eye Hospital Ltd

Dr Agarwal’s Eye Hospital, founded in 1957 and registered in 1994 as a Company, is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the company has been a pioneer and leader in the Ophthalmology market with an established market position and healthy brand recall in the eye care segment. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The company provides comprehensive services across all major ophthalmic specialities. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The hospital uses advanced diagnostic technology, precision surgical systems and global best practices to ensure accurate treatment outcomes. Each speciality is supported by dedicated teams trained in complex procedures and emerging innovations.

Business area of the company

Dr Agarwals Eye Hospital is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

Eye Treatments & Surgery

  • Trabeculectomy Surgery for Glaucoma
  • Glaucoma Shunt Surgery
  • Silk LASIK
  • Laser Trabeculoplasty for Glaucoma Treatment
  • YAG Peripheral Iridotomy (YAG PI)
  • Minimally Invasive Glaucoma Surgery (MIGS)
  • Robotic Cataract
  • Central Serous Retinopathy (CSR)
  • Hyperopia
  • Stye Eye Treatment
  • Refractive Surgery
  • Myopia
  • Contoura Lasik
  • Lasik Surgery
  • Flapless LASIK
  • Photorefractive Keratectomy (PRK)
  • Implantable Collamer Lens (ICL)
  • Eyelid & Eye Socket Correction (Oculoplasty)
  • Glued IOL
  • CAIRS Eye Surgery
  • Advanced Corneal Transplant (PDEK)
  • Pneumatic Retinopexy (PR)
  • Cornea Transplantation
  • Pinhole Pupilloplasty
  • Paediatric Ophthalmology
  • Cryopexy
  • Retina Injection Therapy (Anti-VEGF)
  • Cosmetic Eye Surgery
  • Dry Eye Treatment
  • Retinal Laser Photocoagulation
  • Retina Repair Surgery (Vitrectomy)
  • Scleral Buckle
  • Laser Cataract Surgery
  • Black Fungus Treatment & Diagnosis
  • Neuro Ophthalmology

You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Address : The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: